NIH study finds routine lab tests fall short in diagnosing long COVID

A National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition

5 takeaways from STAT’s look at unwanted supplies and surprise bills from device maker Zynex Medical

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies,

June 4, 2024

Bright night light exposure increases mortality risk, while daylight reduces it

Study reveals that brighter night light exposure and circadian rhythm disruption significantly increase the risk of mortality, particularly from cardiometabolic diseases, while brighter daytime light

October 17, 2024

UK MHRA approves AbbVie’s migraine prevention drug Aquipta

Phase III data showed that AbbVie’s Aquipta offered a substantial decline in mean monthly migraine days from baseline to 12 weeks. Credit: baranq/Shutterstock.com. The UK

September 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.